Laura Dillon

Laura Dillon is the VP, Translational Medicine & Bioinformatics, responsible for designing and implementing Parthenon's biomarker strategy. She has over 15 years of experience in the industry, academia, and government. Prior to joining Parthenon, Laura was the Director of Pathology Data Strategy at AstraZeneca, focusing on the development of novel methodologies to extract information from imaging datasets and the implementation of non-invasive bioimaging techniques to advance the drug development pipeline. Laura has a Ph.D. in Bioinformatics and Genomics from the University of Maryland.